Argyria is caused by a buildup of silver in the body, which discolors the skin.
An 84-year-old man left clinicians at a Hong Kong hospital utterly perplexed after arriving at the hospital to be treated […] ...
Disc Medicine finalised the pivotal Phase III trial design of bitopertin in erythropoietic protoporphyria (EPP) with the FDA ...
Managing the unpredictable symptoms of indolent systemic mastocytosis prompted a search for answers and community.
Epidermolysis Bullosa (EB), or butterfly disease, affects 1 in 50,000 people, causing fragile skin that blisters easily, ...
Researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants.
LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical and transdermal pharmaceutical research and ...
Morningstar brands and products Company Portfolio ...
Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.
Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.